Publications

Targeting microbiota-generated acetaldehyde to prevent progression of metabolic dysfunction- associated steatotic liver disease

 49
Targeting microbiota-generated acetaldehyde to prevent progression of metabolic dysfunction- associated steatotic liver disease

Tags:

Previous Article

Astrocyte-microglia crosstalk in thalamocortical synapse refinement

Next Article

Microbiota-generated acetaldehyde in the progression of liver disease

Related Posts

Cervicovaginal microbiome and natural history of Chlamydia trachomatis in adolescents and young women

Cervicovaginal microbiome and natural history of Chlamy...

 85

A μ-opioid receptor superagonist analgesic with minimal adverse effects

A μ-opioid receptor superagonist analgesic with minimal...

 116

Amyloid precursor protein carboxy-terminal fragments as catalyzers of endolysosomal dysfunction in Alzheimer’s disease

Amyloid precursor protein carboxy-terminal fragments as...

 107